Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2019 1
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 1 Pulmonary Fistula, CTCAE"
Page 1
Proton therapy for the treatment of inflammatory breast cancer.
Fattahi S, Mullikin TC, Aziz KA, Afzal A, Smith NL, Francis LN, Harmsen WS, Routman DM, Remmes NB, Ahmed SK, Shumway DA, Park SS, Mutter RW, Corbin KS. Fattahi S, et al. Radiother Oncol. 2022 Jun;171:77-83. doi: 10.1016/j.radonc.2022.04.008. Epub 2022 Apr 15. Radiother Oncol. 2022. PMID: 35436537 Free article.
One patient with pre-existing surgical seroma experienced a grade 3 fistula. Mean heart, left anterior descending artery, and right coronary artery doses were 0.7 Gy, 2.3 Gy, and 0.1 Gy, respectively. Mean ipsilateral lung V20Gy was 14.9%. At 2 years, …
One patient with pre-existing surgical seroma experienced a grade 3 fistula. Mean heart, left anterior descending artery, and …
Complications after 100 sessions of cone-beam computed tomography-guided lung radiofrequency ablation: a single-center, retrospective experience.
Kim MS, Hong HP, Ham SY, Koo DH, Kang DY, Oh TY. Kim MS, et al. Int J Hyperthermia. 2020;37(1):763-771. doi: 10.1080/02656736.2020.1784472. Int J Hyperthermia. 2020. PMID: 32619365 Free article.
The major and minor complication rates were 5% and 28%, respectively. The major complications were significant pulmonary hemorrhage (1%), large hemothorax requiring drainage (1%), pneumonia treated with antibiotics (2%), and delayed bronchopleural fistula …
The major and minor complication rates were 5% and 28%, respectively. The major complications were significant pulmonary hemorrhage ( …
Percutaneous cryoablation for inoperable malignant lung tumors: midterm results.
Chou HP, Chen CK, Shen SH, Sheu MH, Wu MH, Wu YC, Chang CY. Chou HP, et al. Cryobiology. 2015 Feb;70(1):60-5. doi: 10.1016/j.cryobiol.2014.12.004. Epub 2014 Dec 23. Cryobiology. 2015. PMID: 25541142
RESULTS: The immediate during and short-term complications with CTCAE grade 2 or upper include pneumothorax (15%), pleural effusion (20%), pulmonary hemorrhage (24%), pneumonitis (15%), hemothorax (15%), hemoptysis (10%), pain (20%), bronchopleural fistula …
RESULTS: The immediate during and short-term complications with CTCAE grade 2 or upper include pneumothorax (15%), pleural eff …
Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study.
Leppelmann KS, Levesque VM, Bunck AC, Cahalane AM, Lanuti M, Silverman SG, Shyn PB, Fintelmann FJ. Leppelmann KS, et al. Ann Surg Oncol. 2021 Oct;28(11):5829-5839. doi: 10.1245/s10434-021-09714-4. Epub 2021 Feb 23. Ann Surg Oncol. 2021. PMID: 33620616
Five of fifteen recurrent tumors underwent repeat ablation, and secondary technical success was achieved in four (80%). Assisted local tumor control at 1, 2, and 3 years was 96.2%, 89.8%, and 84.9%, respectively. Complications occurred following 24/32 sessions (75.0%) and …
Five of fifteen recurrent tumors underwent repeat ablation, and secondary technical success was achieved in four (80%). Assisted local tumor …
Proton therapy (PT) combined with concurrent chemotherapy for locally advanced non-small cell lung cancer with negative driver genes.
Jin Y, Shimizu S, Li Y, Yao Y, Liu X, Si H, Sakurai H, Xiao W. Jin Y, et al. Radiat Oncol. 2023 Nov 16;18(1):189. doi: 10.1186/s13014-023-02372-8. Radiat Oncol. 2023. PMID: 37974211 Free PMC article.
PURPOSE: To discuss the optimal treatment modality for inoperable locally advanced Non-Small Cell Lung Cancer patients with poor physical status, impaired cardio-pulmonary function, and negative driver genes, and provide clinical evidence. ...Both groups did …
PURPOSE: To discuss the optimal treatment modality for inoperable locally advanced Non-Small Cell Lung Cancer patients with poor phys …
Radiation-related Adverse Effects of CT-guided Implantation of 125I Seeds for Thoracic Recurrent and/or Metastatic Malignancy.
Ji Z, Jiang Y, Guo F, Peng R, Sun H, Wang P, Fan J, Wang J. Ji Z, et al. Sci Rep. 2019 Oct 15;9(1):14803. doi: 10.1038/s41598-019-51458-5. Sci Rep. 2019. PMID: 31616052 Free PMC article.
The median postoperative dose (D90) was 122 Gy (45.7-241.8 Gy). Three patients (3.9%) showed radiation pneumonitis of grade 2. Two patients (2.6%) showed radiation-induced esophagitis of grade 2. One patient (1.3%) showed an esophageal fistula. Two pat …
The median postoperative dose (D90) was 122 Gy (45.7-241.8 Gy). Three patients (3.9%) showed radiation pneumonitis of grade 2. Two pa …